{"id":1015429,"date":"2026-10-29T18:09:38","date_gmt":"2026-10-29T22:09:38","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-8\/"},"modified":"2026-10-29T18:09:38","modified_gmt":"2026-10-29T22:09:38","slug":"veracyte-to-participate-in-upcoming-investor-conferences-8","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-8\/","title":{"rendered":"Veracyte to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SOUTH SAN FRANCISCO, Calif., Oct.  29, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OspObDlMnYGgYhESr7ftc5jvU7zmp_xKoHXIb51DVauuSuhKGFWQp8KFv_ZnjOYNDGhqlrAW8cdtgI8Wb0GcicywzcS24bg0hYhJimj8pXU=\" rel=\"nofollow\" target=\"_blank\">Veracyte, Inc.<\/a> (Nasdaq: VCYT), a leading cancer diagnostics company, today announced it will be participating in the following investor conferences:<\/p>\n<ul type=\"disc\">\n<li>\n          <strong>UBS Global Healthcare Conference<\/strong>\u00a0\u2013\u00a0Palm Beach Gardens, FL<br \/>Fireside chat on\u00a0Tuesday, November 10 at\u00a04:15 p.m. Eastern Time<\/li>\n<li>\n          <strong>Jefferies Global Healthcare Conference<\/strong>\u00a0\u2013\u00a0London, UK\u00a0<br \/>Fireside chat on\u00a0Wednesday, November 18 at\u00a02:30 p.m. Greenwich Mean Time<\/li>\n<li>\n          <strong>Stephens Annual Investment Conference<\/strong> \u2013 Nashville, TN<br \/>Fireside chat on\u00a0Thursday, November 19 at\u00a09:30 a.m. Central Time<\/p>\n<\/li>\n<\/ul>\n<p>Live audio webcasts of the company\u2019s presentations will be available by visiting Veracyte\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OM5nZNd2unXcbCw4vS-3ATf8oF70VOiAk258427DPRcYzLHWWrTW8iLSclbFQHHA2jLsAIWSL9jeWiILSajuaMANWc25AAokP0txW-JZx18nuhcYkyVDNH0ZsaLh9rbJ0q9Vk5rEnq6fyo8P3W3dnWamZtn_ZwRO5ENAM4LkO2c=\" rel=\"nofollow\" target=\"_blank\">http:\/\/investor.veracyte.com\/events-presentations<\/a>. Replays of the webcasts will be available for 90 days after each live presentation broadcast.<\/p>\n<p>\n        <strong>About\u00a0Veracyte<\/strong><br \/>\n        <br \/>Veracyte\u00a0(Nasdaq: VCYT) is a global diagnostics company with a vision to transform cancer care for patients around the world. The company\u2019s molecular tests assess the unique biology of each patient\u2019s tumor to help clinicians answer essential questions about cancer care.\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OspObDlMnYGgYhESr7ftcyevFImp1j3g2J_sI6BgEXlq2l4ujpVrXV2Mb5j8kbxWf6tImw88fA97EDSvEW3f90dS84zKltqoUFawbVFPi74XHVKzpx7tGV7LsMHpdGTMwaJ55lcju0HcV759xLUo8MOyE1xp_PWHgbwHlrqMdl8=\" rel=\"nofollow\" target=\"_blank\">Veracyte\u2019s Diagnostics Platform<\/a>\u00a0combines broad genomic and clinical data, advanced bioinformatics and AI, and a powerful evidence-generation engine to support continued\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=puxpW1poGJcF-YINWI9QP4Ti7CqlVZKbbXXR1cDoeAaWwpiY31-V6gAi_74BFB8V2NcRAZmkuj-9-B59AAfQXpTvlK8B19FEhrRbK9FLKdbF78dykDpLzpQibZ6YOFG55PZ3NbQYv6std-TDIt4OhHAQ_RpnAbI2Q5wyCVZQhX8=\" rel=\"nofollow\" target=\"_blank\">innovation and pipeline development<\/a>. The company\u2019s portfolio includes the\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RQ538IqffJLqaPvyKVdQiwS-8qCgwdinYSwY2RpgWp5Or8JhCdsgES3uxkH1RDxPXj_aGy9uz1Drw_hYOFIjZB9rjrhIg1EPMHgEi3q-66nJ4dR9YaJHVAs0VFR0OHAvhNDkUctnjcsQjkjISwqPS6ZMeOaUURCxMV_KjrtqHIs=\" rel=\"nofollow\" target=\"_blank\">Afirma\u00ae Genomic Sequencing Classifier test<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1IseAKPt79wheYLol7UOi718dlwd7V6HrD3qYBVGSJU3Qg0lT4H-Gk6gPIRFUXrTK9CfFKLZxPrlD0yngETFzsm5NEIV8nT9zdQag7ikyt4eJ_giVka7jzIWMih1InjOi7wA7ojnK_OwaFujLEVXCrli2Pb4jQK9gA8NvZUbxDI=\" rel=\"nofollow\" target=\"_blank\">Decipher\u00ae Bladder Genomic Classifier test<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1IseAKPt79wheYLol7UOi5NFdfNwgr-VWdlKiHmW7AH-9Il7ignjxFJfh983pf10BriwlH1FMxXLWHpTbiRMaqj2S2EvTF4v-rt89fp7g2KQ1v7C91BCKkDhp-ryCzYK-w-9cxBU_RFgcbXrzPPHDmfLtrHmKjYLdjGJL-fQvlI=\" rel=\"nofollow\" target=\"_blank\">Decipher\u00ae Prostate Genomic Classifier test<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KXXgYNsCLVkQSa7JWzPqZz4-FTk3RHdKkvoQa5urqu0YxV4pZjUhvqhwpwaDWckxlqgoR0uoE-1B3eQ6kYKc8priK-anrBhDLxRYo6MrBJe6-lL9VnAkD-qxh3bUiPyf-q24zFhlRaRGKH6mkWgKaycBa8Xr2_Lpu9LZ5najYbA=\" rel=\"nofollow\" target=\"_blank\">Prosigna\u00ae Breast Risk of Recurrence test<\/a>, and the\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5BGtk6hMOowkCVuyOC-YKhAriC3_i4aGYhVwEAT9arp4VNeVDyivnV-S33ryy2kRCtfZkVx9EIv1_vk_haAMVYwBvDvwlFxzanGHpG-68X6q6VYdtMvNHMYs30I90e2NC8SO95oiuUXNIu8OapINFg==\" rel=\"nofollow\" target=\"_blank\">TrueMRD\u2122 Monitoring Test for MIBC<\/a>. For more information, visit Veracyte\u2019s\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=byOiddQVOn-Jd_zEuCd5es6c36N5KjOuUdnhN3nCTs9dbLveNk-iQznAh6rBv4uPnph9oHTzn84gnC8xORW0DA==\" rel=\"nofollow\" target=\"_blank\">website<\/a>\u00a0or follow the company on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wbn2FRh2xolc9vfUlid8bpPxEdlkKCfwV3pLwPSlwhF0HGhK5MK2ksTLBJJizEypcElxgvP30CbY5thq-PHQIYlTamAjglzKkmUxPXaUub8=\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>\u00a0or\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=h4pnvvfTtjmSPezqn44PHEVVe3pKkqtrdlbdY2vcN27m7FSppsQuzvqtW3kziKhwQ_7DaLv5OI3M8dIVlajLOw==\" rel=\"nofollow\" target=\"_blank\">X (Twitter)<\/a>.<\/p>\n<p>\n        <strong>Investors:<\/strong><br \/>\n        <br \/>Kelly Gura<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=F34A9KzcQKb4GxexkOyTvcwx5ZWVjrhlUd2SlnvhXZ5W-OOgrMVLyzc8mP6W1SPTEEMOdfsTNEuyiOJX83UNaOhEB_hp5lWnLcyGPmRn9B4=\" rel=\"nofollow\" target=\"_blank\">investors@veracyte.com<\/a><\/p>\n<p><strong>Media:<\/strong><br \/>Molly Cornbleet<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QojDZMMiPE_kx9vz9eOwaxrhevrz_AVQNXoTyESW_9DerDzNVgrS3O076zGEd3zFw08LFIxwm6zppwI6UO5-vttzEy5Cis4vUkwXR0xk4Gk=\" rel=\"nofollow\" target=\"_blank\">media@veracyte.com<\/a><br \/>+1-650-351-8780<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NjQxOSM3OTE5NTAwIzIwMDY2ODg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/Mjg3MzE1ZjUtNWY0ZC00ZDFjLTljNDctY2FhMjc5ZGJiY2U0LTEwMTgyNjEtMjAyNi0xMC0yOS1lbg==\/tiny\/Veracyte-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOUTH SAN FRANCISCO, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) &#8212; Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced it will be participating in the following investor conferences: UBS Global Healthcare Conference\u00a0\u2013\u00a0Palm Beach Gardens, FLFireside chat on\u00a0Tuesday, November 10 at\u00a04:15 p.m. Eastern Time Jefferies Global Healthcare Conference\u00a0\u2013\u00a0London, UK\u00a0Fireside chat on\u00a0Wednesday, November 18 at\u00a02:30 p.m. Greenwich Mean Time Stephens Annual Investment Conference \u2013 Nashville, TNFireside chat on\u00a0Thursday, November 19 at\u00a09:30 a.m. Central Time Live audio webcasts of the company\u2019s presentations will be available by visiting Veracyte\u2019s website at http:\/\/investor.veracyte.com\/events-presentations. Replays of the webcasts will be available for 90 days after each live presentation broadcast. About\u00a0Veracyte Veracyte\u00a0(Nasdaq: VCYT) is a global diagnostics company with a vision to transform cancer care &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-8\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Veracyte to Participate in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1015429","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Veracyte to Participate in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-8\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Veracyte to Participate in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) &#8212; Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced it will be participating in the following investor conferences: UBS Global Healthcare Conference\u00a0\u2013\u00a0Palm Beach Gardens, FLFireside chat on\u00a0Tuesday, November 10 at\u00a04:15 p.m. Eastern Time Jefferies Global Healthcare Conference\u00a0\u2013\u00a0London, UK\u00a0Fireside chat on\u00a0Wednesday, November 18 at\u00a02:30 p.m. Greenwich Mean Time Stephens Annual Investment Conference \u2013 Nashville, TNFireside chat on\u00a0Thursday, November 19 at\u00a09:30 a.m. Central Time Live audio webcasts of the company\u2019s presentations will be available by visiting Veracyte\u2019s website at http:\/\/investor.veracyte.com\/events-presentations. Replays of the webcasts will be available for 90 days after each live presentation broadcast. About\u00a0Veracyte Veracyte\u00a0(Nasdaq: VCYT) is a global diagnostics company with a vision to transform cancer care &hellip; Continue reading &quot;Veracyte to Participate in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-8\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-29T22:09:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NjQxOSM3OTE5NTAwIzIwMDY2ODg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-participate-in-upcoming-investor-conferences-8\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-participate-in-upcoming-investor-conferences-8\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Veracyte to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2026-10-29T22:09:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-participate-in-upcoming-investor-conferences-8\\\/\"},\"wordCount\":256,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-participate-in-upcoming-investor-conferences-8\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NjQxOSM3OTE5NTAwIzIwMDY2ODg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-participate-in-upcoming-investor-conferences-8\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-participate-in-upcoming-investor-conferences-8\\\/\",\"name\":\"Veracyte to Participate in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-participate-in-upcoming-investor-conferences-8\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-participate-in-upcoming-investor-conferences-8\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NjQxOSM3OTE5NTAwIzIwMDY2ODg=\",\"datePublished\":\"2026-10-29T22:09:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-participate-in-upcoming-investor-conferences-8\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-participate-in-upcoming-investor-conferences-8\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-participate-in-upcoming-investor-conferences-8\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NjQxOSM3OTE5NTAwIzIwMDY2ODg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NjQxOSM3OTE5NTAwIzIwMDY2ODg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-participate-in-upcoming-investor-conferences-8\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Veracyte to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Veracyte to Participate in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-8\/","og_locale":"en_US","og_type":"article","og_title":"Veracyte to Participate in Upcoming Investor Conferences - Market Newsdesk","og_description":"SOUTH SAN FRANCISCO, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) &#8212; Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced it will be participating in the following investor conferences: UBS Global Healthcare Conference\u00a0\u2013\u00a0Palm Beach Gardens, FLFireside chat on\u00a0Tuesday, November 10 at\u00a04:15 p.m. Eastern Time Jefferies Global Healthcare Conference\u00a0\u2013\u00a0London, UK\u00a0Fireside chat on\u00a0Wednesday, November 18 at\u00a02:30 p.m. Greenwich Mean Time Stephens Annual Investment Conference \u2013 Nashville, TNFireside chat on\u00a0Thursday, November 19 at\u00a09:30 a.m. Central Time Live audio webcasts of the company\u2019s presentations will be available by visiting Veracyte\u2019s website at http:\/\/investor.veracyte.com\/events-presentations. Replays of the webcasts will be available for 90 days after each live presentation broadcast. About\u00a0Veracyte Veracyte\u00a0(Nasdaq: VCYT) is a global diagnostics company with a vision to transform cancer care &hellip; Continue reading \"Veracyte to Participate in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-8\/","og_site_name":"Market Newsdesk","article_published_time":"2026-10-29T22:09:38+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NjQxOSM3OTE5NTAwIzIwMDY2ODg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-8\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-8\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Veracyte to Participate in Upcoming Investor Conferences","datePublished":"2026-10-29T22:09:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-8\/"},"wordCount":256,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-8\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NjQxOSM3OTE5NTAwIzIwMDY2ODg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-8\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-8\/","name":"Veracyte to Participate in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-8\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-8\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NjQxOSM3OTE5NTAwIzIwMDY2ODg=","datePublished":"2026-10-29T22:09:38+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-8\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-8\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-8\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NjQxOSM3OTE5NTAwIzIwMDY2ODg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NjQxOSM3OTE5NTAwIzIwMDY2ODg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-8\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Veracyte to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1015429","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1015429"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1015429\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1015429"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1015429"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1015429"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}